南京英派药业股份有限公司（英派药业-B，07630）9月3日自愿公告称，执行董事兼首席执行官蔡遂雄博士近期在公开市场合计买入100,000股公司普通股，每股平均价格约14.6105港元，增持股份占公司已发行股份总数约0.035%。\n\n本次增持后，蔡遂雄博士合共持有18,540,884股公司股份，占截至公告日期已发行股本总额约6.564%。\n\n公告指出，蔡遂雄博士对公司整体发展前景及潜在增长保持信心，并在遵守适用法律及监管规定的前提下，不排除未来继续增持股份的可能性。\n\n公司提醒股东及潜在投资者在买卖公司证券时保持审慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.